Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol, Version 6, 08 Jul 2020, MHRA
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
G. Organisation Responsibilities
Appendix I - Expectations for Specific Serious Breach Topics
Appendix II Examples of Serious Breaches Notified to MHRA (this is not an exhaustive list)
Source: Medicines & Healthcare products Regulatory Agency, the UK.
Clinical Research News
今後の臨床試験
-
NCT05897801募集気道感染症 | 細菌感染症 | ウイルス感染 | 多剤耐性
-
NCT05897398まだ募集していません肥満 | サルコペニア肥満 | 肥満手術 | むちゃ食い障害 | 向精神薬 | 症候性肥満 | 医原性肥満
Clinical Research Jobs
-
Country Approval Specialist (Study Start-Up Submissions Specialist) - Belgium
-
(Associate) Medical Director - Ophthalmology, EMEA
-
Implementation Engineer-1
-
Principal RWD Solutions Leader
-
Senior Clinical Research Associate
-
Clinical Finance Systems Analyst - FSP
-
Company Car Fleet & Travel Manager
-
Regulatory Submissions Technical Advisor
-
Freelance- Translators/Linguists, English into Danish
-
Freelance- Translators/Linguists, English into Estonian
-
Central Services Specialist - Insurance/Sponsor Statements
-
Clinical Research Associate ll-lll- Vaccines - Home-Based (US) - California